Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 11 studies | 26% ± 10% | |
glutamatergic neuron | 7 studies | 30% ± 19% | |
oligodendrocyte precursor cell | 6 studies | 31% ± 6% | |
podocyte | 5 studies | 48% ± 13% | |
neuron | 3 studies | 24% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 9 studies | 26% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 8128.92 | 2641 / 2642 | 100% | 37.23 | 704 / 705 |
skin | 95% | 3067.53 | 1716 / 1809 | 99% | 33.08 | 465 / 472 |
uterus | 83% | 1265.84 | 141 / 170 | 90% | 8.47 | 412 / 459 |
ovary | 100% | 12116.47 | 180 / 180 | 70% | 6.63 | 300 / 430 |
lung | 83% | 1194.69 | 480 / 578 | 76% | 6.02 | 879 / 1155 |
esophagus | 64% | 1194.99 | 924 / 1445 | 91% | 7.47 | 166 / 183 |
pancreas | 65% | 724.65 | 212 / 328 | 89% | 4.96 | 159 / 178 |
stomach | 59% | 652.11 | 213 / 359 | 65% | 4.73 | 187 / 286 |
adrenal gland | 85% | 1068.69 | 220 / 258 | 31% | 2.57 | 72 / 230 |
breast | 59% | 1815.71 | 271 / 459 | 54% | 3.01 | 607 / 1118 |
kidney | 89% | 3694.98 | 79 / 89 | 22% | 1.20 | 199 / 901 |
prostate | 50% | 535.59 | 123 / 245 | 57% | 2.68 | 288 / 502 |
intestine | 40% | 443.13 | 384 / 966 | 62% | 4.32 | 328 / 527 |
eye | 0% | 0 | 0 / 0 | 100% | 60.78 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.14 | 1 / 1 |
bladder | 24% | 213.24 | 5 / 21 | 74% | 5.66 | 372 / 504 |
spleen | 98% | 2166.44 | 235 / 241 | 0% | 0 | 0 / 0 |
adipose | 91% | 2952.42 | 1099 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 6.58 | 41 / 45 |
thymus | 2% | 16.70 | 12 / 653 | 60% | 3.99 | 363 / 605 |
liver | 2% | 18.84 | 4 / 226 | 33% | 3.61 | 136 / 406 |
heart | 17% | 177.16 | 149 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 15% | 183.28 | 201 / 1335 | 0% | 0 | 0 / 0 |
muscle | 2% | 22.07 | 18 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0007283 | Biological process | spermatogenesis |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0001779 | Biological process | natural killer cell differentiation |
GO_0070527 | Biological process | platelet aggregation |
GO_0051250 | Biological process | negative regulation of lymphocyte activation |
GO_0007165 | Biological process | signal transduction |
GO_0007275 | Biological process | multicellular organism development |
GO_1903902 | Biological process | positive regulation of viral life cycle |
GO_0001764 | Biological process | neuron migration |
GO_0007155 | Biological process | cell adhesion |
GO_0042698 | Biological process | ovulation cycle |
GO_0051649 | Biological process | establishment of localization in cell |
GO_0030168 | Biological process | platelet activation |
GO_0032940 | Biological process | secretion by cell |
GO_0045824 | Biological process | negative regulation of innate immune response |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0043277 | Biological process | apoptotic cell clearance |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0060068 | Biological process | vagina development |
GO_0034446 | Biological process | substrate adhesion-dependent cell spreading |
GO_0070050 | Biological process | neuron cellular homeostasis |
GO_0006909 | Biological process | phagocytosis |
GO_0034122 | Biological process | negative regulation of toll-like receptor signaling pathway |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0021885 | Biological process | forebrain cell migration |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0007399 | Biological process | nervous system development |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0016477 | Biological process | cell migration |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005635 | Cellular component | nuclear envelope |
GO_0009986 | Cellular component | cell surface |
GO_0005634 | Cellular component | nucleus |
GO_0043548 | Molecular function | phosphatidylinositol 3-kinase binding |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0001618 | Molecular function | virus receptor activity |
GO_0004714 | Molecular function | transmembrane receptor protein tyrosine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | TYRO3 |
Protein name | Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) TYRO3 protein tyrosine kinase Tyrosine-protein kinase receptor TYRO3 Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF) |
Synonyms | DTK RSE BYK SKY TIF |
Description | FUNCTION: Receptor tyrosine kinase that transduces signals from the extracellular matrix into the cytoplasm by binding to several ligands including TULP1 or GAS6. Regulates many physiological processes including cell survival, migration and differentiation. Ligand binding at the cell surface induces dimerization and autophosphorylation of TYRO3 on its intracellular domain that provides docking sites for downstream signaling molecules. Following activation by ligand, interacts with PIK3R1 and thereby enhances PI3-kinase activity. Activates the AKT survival pathway, including nuclear translocation of NF-kappa-B and up-regulation of transcription of NF-kappa-B-regulated genes. TYRO3 signaling plays a role in various processes such as neuron protection from excitotoxic injury, platelet aggregation and cytoskeleton reorganization. Also plays an important role in inhibition of Toll-like receptors (TLRs)-mediated innate immune response by activating STAT1, which selectively induces production of suppressors of cytokine signaling SOCS1 and SOCS3. .; FUNCTION: (Microbial infection) Acts as a receptor for lassa virus and lymphocytic choriomeningitis virus, possibly through GAS6 binding to phosphatidyl-serine at the surface of virion envelope. .; FUNCTION: (Microbial infection) Acts as a receptor for Ebolavirus, possibly through GAS6 binding to phosphatidyl-serine at the surface of virion envelope. . |
Accessions | H0YN24 H3BPR7 ENST00000559815.1 H0YKZ2 ENST00000559066.5 Q06418 ENST00000568343.1 H0YNK6 ENST00000263798.8 Q8N6J3 ENST00000559851.1 |